SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neopath (NPTH)
NPTH 0.0006000.0%Mar 7 3:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: bazan who wrote (40)8/20/1997 9:41:00 AM
From: Sigmund   of 178
 
In the past, someone commented on AccuMed. Well they got their approval and the stock spiked up. Looks to me like Neopath will apply for their PMA soon. I think they have been telling people the end of August and today is the 2oth.

Maybe the approval of the AccuMed device indicates the FDA is open to approving automation which improves efficiency even if it raises certain kind of risks/tradeoffs.

Anyone have any idea about the lab markets' reaction to the AccuMed device?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext